CALMARE THERAPEUTICS INCORPORATED Calmare Therapeutics Incorporated has appointed Dr. Christine Chansky, M.D., J.D., F.C.L.M., chief regulatory officer (CRO) of Calmare Therapeutics. As part of Dr. Chansky's duties and responsibilities as the Company's chief regulatory officer and corporate executive, she will spearhead all of CTI-sponsored clinical studies, and oversee all global regulatory issues related to the Company's medical device practice. On being offered the opportunity to be CTI's first regulatory officer.
Dr. Chansky's will discontinue her private medical practice and devote all of her time to CTI.
